science
Vera’s TRUTAKNA Launch Set Up A High-Stakes Phase 3 Test

The biotech’s IgAN drug has FDA accelerated approval, but ORIGIN 3 results and a Q4 2026 sBLA will decide how durable that runway looks.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
I turn up late to meetings to dodge small talk. Am I wrong? - Nature
Google News

Esther Rantzen was utterly unique... the entire nation will miss her energy
Express
Simulating death can reduce people’s fear of dying
The Economist
It may soon be possible to create “mirror life”
The Economist

MI5 Issues Rare Public Alert to Stop Chinese Intelligence Benefiting From UK University Research
International Business Times